Evidence. Care. Accountability.Contact the desk
Our standards

Research explained

BPC-157 after dextran or egg-related animal challenges

The study does not validate BPC-157 for emergency treatment of human anaphylaxis.

On this page

Evidence dossier

The report behind the claim

The authors reported attenuation of induced anaphylactoid features with experimental peptide regimens. The study does not validate BPC-157 for emergency treatment of human anaphylaxis.

Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration.

Design
Experimental animal investigation with the intervention and outcomes specified in the indexed abstract.
Participants or model
Anesthetized rats and mice after intravenous challenges
Endpoint
Swelling, respiration and short-term mortality-related observations
Finding on record
The authors reported attenuation of induced anaphylactoid features with experimental peptide regimens.
Limits of inference
The study does not validate BPC-157 for emergency treatment of human anaphylaxis.
Read the publication

The experiment in view

The study used anesthetized rats and mice after intravenous challenges. Its principal measures were swelling, respiration and short-term mortality-related observations. The authors reported attenuation of induced anaphylactoid features with experimental peptide regimens.

Reading the result closely

The term anaphylactoid and the artificial challenge conditions deserve to remain explicit. Human allergic emergencies require established emergency care. A mechanistic animal paper should never be turned into advice to delay that care or replace a proven rescue medicine.

The boundary of the finding

The study does not validate BPC-157 for emergency treatment of human anaphylaxis.

Related evidence, kept separate

BPC-157 and platelet tests after antiplatelet drugs examines platelet aggregation and thromboelastometry. Here, the measured endpoint was swelling, respiration and short-term mortality-related observations. Those outcomes belong to separate experiments; one is not a replication or a human confirmation of the other. Compare that distinction with the What changes when a BPC-157 paper becomes a sales claim? appraisal.

On the record

The documents supporting this report.

  1. BPC-157 after dextran or egg-related animal challenges — original indexed research

The continuing record

More from the report

Before you leave

One more option to compare.

Another provider review

We may earn a commission from qualifying provider referrals. Affiliate placements are labeled Partner. How we are funded

Continue to your choiceRead another review